Sarah Ghamry-Barrin

Sarah Ghamry-Barrin

Auto-generated profile, based on publicly available information

Sarah Ghamry-Barrin

Lyon Immunotherapy for Cancer Laboratory (LICL), Cancer Research Center of Lyon, Centre Léon Bérard, Lyon, France

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 January 2025 in Cancer Immunology Research
Verified
Journal Article
Closed access
EGElisa Gobbini
Elisa Gobbini
MHMargaux Hubert
Margaux Hubert
ADAnne-Claire Doffin
Anne-Claire Doffin
AEAnais Eberhardt
Anais Eberhardt
LHLéo Hermet
Léo Hermet
JVJenny Valladeau-Guilemond
Jenny Valladeau-Guilemond
Dendritic cells (DC) are promising targets for cancer immunotherapies because of their central role in the initiation and control of immune responses. The type 1 conventional DC (cDC1) population is of particular interest because of its ability to cross-present antigens to CD8+ T cells. cDC1s also secrete cytokines that allow Th1 cell polarization and NK cell activation and recruitment. However, the spatial organization and specific functions of cDC1s in response to immunotherapy remain to be clearly characterized in human tumors. In this study, we used a multiplexed immunofluorescence analysis pipeline coupled with computational image analysis to determine the spatial organization of cDC1s in skin lesions from a cohort of patients with advanced melanoma treated with immune checkpoint inhibitors (ICI). For this, we performed a whole-slide image analysis of cDC1 infiltration, distribution, and spatial interaction with key immune partners such as CD8+ T cells and plasmacytoid DCs. We also analyzed LAMP3+ DCs, which correspond to a mature subset of tumor-infiltrating DCs. Distance and cell network analyses demonstrated that cDC1s exhibited a scattered distribution compared with tumor-infiltrating plasmacytoid DCs and LAMP3+ DCs, which were preferentially organized in dense areas with high homotypic connections. The proximity and interactions between CD8+ T cells and cDC1s were positively associated with the response to ICIs. In conclusion, our study unravels the complex spatial organization of cDC1s and their interactions with CD8+ T cells in lesions of patients with melanoma, shedding light on the pivotal role of these cells in shaping the response to ICIs.

4 June 2025 in Clinical Cancer Research
Verified
Journal Article
Closed access
LCLaetitia Collet
Laetitia Collet
MAMaude Ardin
Maude Ardin
DVDavid Venet
David Venet
JBJustine Berthet
Justine Berthet
SGSarah Ghamry-Barrin
Sarah Ghamry-Barrin
OSOlivia Le Saux
Olivia Le Saux
Purpose: To describe PD-L1 expression across tissue types and its associated tumor microenvironment and to investigate how it affects its predictive value for response to pembrolizumab in treatment-naïve patients with ovarian cancer included in the NeoPembrOV phase II trial (NCT03275506). Materials and Methods: PD-L1 expression was assessed for 85 patients (56 on metastasis and 29 on tubo-ovary) using tumor proportion score (TPS) and immune cell (IC) score, considering positivity if ≥1% and high expression if ≥5%. RNA sequencing and multiplex immunofluorescence were conducted. The Australian Ovarian Cancer Study was used as an external validation cohort. Results: PD-L1 was primarily expressed by tumor cells in tubo-ovaries and by ICs in metastases. The IC score assessed on the metastases was associated with a longer progression-free survival in the pembrolizumab arm compared with the control arm. Compared with tubo-ovaries, metastases were enriched in T and B cells as well as in granzyme B (GZMB) CD8 cytotoxic T-cell signatures. In metastases, the IC score was associated with immune infiltration and overexpression of additional immune checkpoints, such as IDO1, LAG3, and ICOS, whereas TPS was associated with cell proliferation, immune infiltration, and IFN-γ pathways. In tubo-ovaries, TPS was associated with pathways linked to cell proliferation and antigen presentation but was depleted in activated immune pathways, and CD274 expression was correlated with hypoxia and PI3K/Akt/mTOR signaling. Conclusions: Distinct PD-L1 expression patterns across tissue types are associated with different biological pathways and tumor microenvironments in ovarian cancer, affecting PD-L1 predictive value. Our results provide novel insights into high-grade serous ovarian cancer biology for tailoring immunotherapy in patients with ovarian cancer.

8 February 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
EGElisa Gobbini
Elisa Gobbini
MHMargaux Hubert
Margaux Hubert
ADAnne-Claire Doffin
Anne-Claire Doffin
AEAnais Eberhardt
Anais Eberhardt
LHLeo Hermet
Leo Hermet
JVJenny Valladeau-Guilemond
Jenny Valladeau-Guilemond
Background: Dendritic cells (DCs) are promising targets for cancer immunotherapies owing to their central role in the initiation and the control of immune responses. Their functions encompass a wide range of mechanisms mediated by different DC subsets. Several studies have identified human tumor- associated DC (TA-DC) populations through limited marker-based technologies, such as immunostaining or flow cytometry. However, tumor infiltration, spatial organization and specific functions in response to immunotherapy of each DC subset remain to be defined. Methods: Here, we implemented a multiplexed immunofluorescence analysis pipeline coupled with bio-informatic analyses to decipher the tumor DC landscape and its spatial organization within melanoma patients’ lesions, and its association with patients’ response to immune checkpoint inhibitors (ICI). For this aim, we analyze a cohort of 41 advanced melanoma patients treated with anti- PD1 alone or associated with anti-CTLA4. Distance and cell network analyses were performed to gain further insight into the spatial organization of tumor-associated DCs. A Digital Spatial Profiling analysis further characterized ecosystem of tumor-infiltrating DCs. Results: Plasmacytoid DCs (pDCs) were the most abundant DC population, followed by conventional cDC1 and mature DCs, present in equal proportions. In contrast to CD8 + T cell frequency, and despite varying densities, all DC subsets were associated with a favorable response to ICI. Distance and cell network analyses demonstrated that tumor-infiltrating DCs were largely organized in dense areas with high homotypic connections, except for cDC1 that exhibited a more scattered distribution. We identified four patterns of ecosystems with distinct preferential interactions between DC subsets. Significantly, the proximity and interactions between CD8 + T cells and cDC1 were positively associated with patients’ response to ICI. Conclusions: Our study unravels the complex spatial organization of DC subsets and their interactions in melanoma patient lesions, shedding light on their pivotal role in shaping the response to ICI. Our discoveries regarding the spatial arrangement of cDC1, especially with CD8+ T cells, provide valuable clues for improving immunotherapeutic strategies in melanoma patients. What is already known on this topic: Dendritic cells (DCs) are promising targets for cancer immunotherapies owing to their central role in the initiation and the control of immune responses. Although conventional type 1 dendritic cells (cDC1) were proposed to contribute to immunotherapy response, their precise functions and interactions with other immune populations in human cancers are largely unknown. What this study adds: This study provides a precise characterization of the spatial distribution and organization of tumor- infiltrating DCs in a large cohort of advanced melanoma patients, and in correlation with response to immunotherapy. While DCs are organized in dense areas with high homotypic connections, cDC1 exhibit a more scattered distribution and form heterotypic aggregates with other DC subsets. More importantly, a close connection between cDC1 and CD8 T cell is uniquely correlated with the patients’ response to immunotherapy. How this study might affect research, practice or policy: This study improves our understanding of CD8-DC spatial organization within the tumor microenvironment and will have a broad spectrum of implications in the design of anti-tumor immune-activating compounds and the design of biomarkers of response to immunotherapy for melanoma patients.

2 April 2025
Verified
Other
Open access
EGElisa Gobbini
Elisa Gobbini
MHMargaux Hubert
Margaux Hubert
ADAnne-Claire Doffin
Anne-Claire Doffin
AEAnais Eberhardt
Anais Eberhardt
LHLéo Hermet
Léo Hermet
JVJenny Valladeau-Guilemond
Jenny Valladeau-Guilemond
Dendritic cells (DC) are promising targets for cancer immunotherapies because of their central role in the initiation and control of immune responses. The type 1 conventional DC (cDC1) population is of particular interest because of its ability to cross-present antigens to CD8+ T cells. cDC1s also secrete cytokines that allow Th1 cell polarization and NK cell activation and recruitment. However, the spatial organization and specific functions of cDC1s in response to immunotherapy remain to be clearly characterized in human tumors. In this study, we used a multiplexed immunofluorescence analysis pipeline coupled with computational image analysis to determine the spatial organization of cDC1s in skin lesions from a cohort of patients with advanced melanoma treated with immune checkpoint inhibitors (ICI). For this, we performed a whole-slide image analysis of cDC1 infiltration, distribution, and spatial interaction with key immune partners such as CD8+ T cells and plasmacytoid DCs. We also analyzed LAMP3+ DCs, which correspond to a mature subset of tumor-infiltrating DCs. Distance and cell network analyses demonstrated that cDC1s exhibited a scattered distribution compared with tumor-infiltrating plasmacytoid DCs and LAMP3+ DCs, which were preferentially organized in dense areas with high homotypic connections. The proximity and interactions between CD8+ T cells and cDC1s were positively associated with the response to ICIs. In conclusion, our study unravels the complex spatial organization of cDC1s and their interactions with CD8+ T cells in lesions of patients with melanoma, shedding light on the pivotal role of these cells in shaping the response to ICIs.

1 August 2025
Verified
Other
Open access
PDF file
LCLaetitia Collet
Laetitia Collet
MAMaude Ardin
Maude Ardin
DVDavid Venet
David Venet
JBJustine Berthet
Justine Berthet
SGSarah Ghamry-Barrin
Sarah Ghamry-Barrin
OSOlivia Le Saux
Olivia Le Saux
Supplementary Figure 1. Flow chart of the population and biomarkers analyses.

17 June 2026
Verified
Other
Open access
PDF file
EGElisa Gobbini
Elisa Gobbini
MHMargaux Hubert
Margaux Hubert
ADAnne-Claire Doffin
Anne-Claire Doffin
AEAnais Eberhardt
Anais Eberhardt
LHLéo Hermet
Léo Hermet
JVJenny Valladeau-Guilemond
Jenny Valladeau-Guilemond
Optimized immunofluorescence staining conditions for the multiplex immunofluorescence panel